期刊文献+

蒙西医结合治疗骨髓增生异常/骨髓增殖性疾病伴环形铁粒幼细胞及血小板增多(MDS/MPN-RS-T)体会

下载PDF
导出
摘要 骨髓增生异常/骨髓增殖性疾病伴环形铁粒幼细胞及血小板增多(MDS/MPN-RS-T)是一种罕见病,发病率极低,主要见于老年人,蒙西医结合治疗疗效明显,故分享并谈体会,为今后的研究及治疗提供参考。
作者 丰艳花
出处 《中国民族医药杂志》 2020年第7期32-33,53,共3页 Journal of Medicine and Pharmacy of Chinese Minorities
  • 相关文献

参考文献6

二级参考文献39

  • 1VARDIMAN J W, BENNETT J M, BAIN B J, et al. Myelodysplastie/myeloproliferative neoplasm, unclassifiable [M]// SWERDLOW S H,CAMPO E,HARRIS N L,et al. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th Ed. Lyon, France: IARC Press: 2008 : 85-86. 被引量:1
  • 2MALCOVATI L,DELLA PORTA M G,PIETRA D, et al. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis[J]. Blood, 2009,114 : 3538- 3545. 被引量:1
  • 3RAYA J M, ARENILLAS L, DOMINCAD A, et al. Refractory anemia with tinged sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status[J]. Int J Hematol, 2008,88 : 387 -395. 被引量:1
  • 4GUREVICH I, LUTHRA R, KONOPLEV S N, et al. Refractory anemia with ring sideroblasts associated with marked thrombocytosis[J]. Am J Clin Pathol, 2011,135 :398-403. 被引量:1
  • 5SCHMITT-GRAEFF A H, TEO S S, OLSCHEWSKI M, et al. JAK2 V617F mutation status identifies subtypes of refractory anaemia with ringed sideroblasts associated with marked thrombocytosis[J]. Haematologica, 2008, 93:34-40. 被引量:1
  • 6PICH A, GODIO L. Refractory anaemia with ring sideroblasts associated with marked thrombocytosis (RARS- T) and JAK2 (V617F) mutation transformed to acute myeloid leukaemia with chromosomal evolution including monosomy 7[J]. Leuk Res,2010,34:e69-e70. 被引量:1
  • 7SZPURKA H, JANKOWSKA A M, MAKISHIMA H, et al. Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations[J]. Leuk Res, 2010,34 : 969 -973. 被引量:1
  • 8CEESAY M M,LEA N C,INGRAM W,et al. The JAK2 V617F mutation is rare in RARS but common in RARS- T[J]. Leukemia, 2006,20:2060-2061. 被引量:1
  • 9SZPURKA H, TIU R, MURUGESAN G, et al. Refractory anemia with ringed sideroblasts associated with marked thrombocytosis ( RARS-T ), another myeloproliferative condition characterized by JAK2 V617F mutation [J]. Blood, 2006,108 : 2173-2181. 被引量:1
  • 10HULS G, MULDER A B, ROSATI S, et al. Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring siderohlasts and thrombocytosis[J]. Blood, 2010,116 : 180 - 182. 被引量:1

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部